RA Capital Management (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization. RA Capital`s scientifically trained research team is intensely data driven in its continual effort to identify early breakthroughs and originate conviction in new ideas. The team`s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.
New York Global Group Inc is a New York, NY-based company in the Financial Services sector.
Gilbert Global is an institutional investment firm that makes private equity and equity-related investments in both public and private companies around the world. Today, Gilbert Global has a capital base of US $1.2 billion. Our principal investors are
The Baupost Group, L.L.C. was established in 1982, and today manages approximately $4.0 billion of equity capital for a diverse group of clients. The firm employs a value oriented investment philosophy and is an experienced investor in a broad range of asset classes, both in the United States and abroad.